Google Groups no longer supports new Usenet posts or subscriptions. Historical content remains viewable.
Dismiss

Pfizer's disgusting behavior in the Zoloft case (Andy Vickery/Ralph Nader)

0 views
Skip to first unread message

Mort Zuckerman

unread,
Apr 6, 2010, 2:30:51 PM4/6/10
to
To: ca...@drcarolgoodheart.com, lPick...@cdc.gov,
Durlan...@yale.edu, Aa...@columbia.edu, gary_w...@nymc.edu,
scientifi...@ostp.gov, pkru...@princeton.edu,
Stanle...@fiu.edu, emcsw...@niaid.nih.gov, afa...@niaid.nih.gov,
Spin...@yahoogroups.com, kshe...@calea.org, fit...@gmail.com,
patrick.f...@usdoj.gov, model...@sbcglobal.net,
jdr...@nejm.org, let...@courant.com, Jgerb...@cdc.gov,
michae...@po.state.ct.us, con...@po.state.ct.us, executive-
edi...@nytimes.com, managin...@nytimes.com, news-
ti...@nytimes.com, biz...@nytimes.com, for...@nytimes.com,
nati...@nytimes.com, dv...@cdc.gov, brigidc...@optonline.net,
tr...@hotmail.com, illino...@aol.com, jle...@courant.com,
tinaj...@yahoo.com, jhorn...@fff.org, thomas...@usdoj.gov,
thoma...@po.state.ct.us, kur...@washpost.com,
georg...@washpost.com, p...@allegorypress.com,
commissi...@po.state.ct.us, brans...@comcast.net,
vts...@comcast.net, o...@po.state.ct.us, freet...@charter.net,
scott....@po.state.ct.us, govern...@po.state.ct.us,
attorney...@po.state.ct.us, randall...@usdoj.gov,
Robert....@yale.edu, edi...@greenwich-post.com,
harol...@yale.edu, sedm...@nswbc.org, rrmcg...@aol.com,
fr...@nytimes.com, dpr...@stmartin.edu, saint....@sbcglobal.net
Cc: fra...@ucia.gov, dr-ahma...@president.ir,
eugener...@washpost.com, afa...@niaid.nih.gov,
bmi...@newstimes.com, tr...@hotmail.com, rast...@aol.com,
billc...@gmail.com, amcg...@rms-law.com, rjmu...@aol.com,
paulcrai...@yahoo.com, criminal...@usdoj.gov,
karla.d...@usdoj.gov, christophe...@usdoj.gov,
richar...@yale.edu, harol...@yale.edu, james.p...@yale.edu,
inq...@aldf.com, ly...@idsociety.org, meganm...@theatlantic.com

Subject: Pfizer's disgusting behavior in the Zoloft case (Andy Vickery/
Ralph Nader)

Date: Apr 6, 2010 2:25 PM

ARTICLE BELOW
==============================

http://justiceseekers.com/default.aspx?menuitemid=199

Yeah, I explained to Andy Vickery
(and sent him documents) the concept
of psychotropics-induced agitation, even
to include Pfizer's publication on the
TREATMENT of psychotropics-induced agitation:
http://www.actionlyme.org/BRAINDAMAGE.htm
"Here's how we recommend treating the
agitation caused by our SSRIs:
http://www.ncbi.nlm.nih.gov/pubmed/9694033

If they published how to TREAT this
brain damage, they clearly acknowledge
the damage occurs, duh.

Vickery then made a video out of the
concept. In the video, Vickery explains
what disgusting behavior on the part
of Pfizer's lawyers he and his client
had to endure. So, it is worth watching
although it isn't exactly technically,
100% correct.

Pfizer's repertoire of dirty tricks
is quite extensive. Here's another one:
http://www.actionlyme.org/070518.htm
"Bribes and Spies in the Drug Industry"

Now, as I have a monster of a headache
I won't go into "Lyrica" and Neurontin
(again) as GABA analogs or agonists, or
the meaning of it all. The meaning is
implied; GABA is the treatment for the
EXACT, SPECIFIC brain damage executed
by phenothiazines, (as I previously mentioned
but you can find the reference here:
http://www.actionlyme.org/BRAINDAMAGE.htm )
And yes, people get a buzz off of it,
like they get a buzz off of Neurontin.

How to check? Ask one of the addicts to
quit that drug: THERE you will see
the destruction of the personality.

As I said, I'm not going into it.
It's a tranquilizer, but not an opiate.
Not a benzo. It treats, in fact, the
PTSD/abuse of FibroLymezalgia victims
by the self-alleged medical profession:
http://www.actionlyme.org/081030.htm
Fibro is not real anyway. It's a
trap diagnosis, which further entraps
the victims of this ruse by having them
say they feel better from this new kind
of stoner-drug, NeurontoLyrica.

Nevertheless, BigPharma's bag of dirty
tricks knows no ethical or international
bounds. The worse offender is SmithKline.

Pfizer, to me, ought to stop buying companies
as a means to make money and start dealing
with the New Medical Paradigm. This is their
punishment for neglecting Lyme victims.
They have nothing. They missed the BIG ONE.


Kathleen M. Dickson
http://www.actionlyme.org
http://www.relapsingfever.org
=====================================
http://www.counterpunch.org/nader04062010.html

Why would Pfizer, the world’s largest drug company, so mistreat and
silence one of their top molecular biologists that a federal jury in
Connecticut awarded her $1.37 million in damages last week?

The unraveling answer promises to tear open the curtain covering
hazards confronting tens of thousands of scientists and assistants in
corporate and university labs doing genetic engineering work with
viruses and bacteria.

Becky McClain’s lawsuit against Pfizer claimed that the company’s
sloppiness in 2002-03 exposed her to an engineered form of the
lentivirus, a virus related to one that could lead to immune
deficiencies. Pfizer denied any connection between its lab practices
and Ms. McClain’s recurring paralysis and other illnesses.

Back and forth over three years came the scientist’s claims and
Pfizer’s denials during which she had to leave her job amidst the
increasing retaliatory behavior of her ten-year employer.

Pfizer is known for playing hardball and violating laws. Last year it
had to pay the Justice Department one of the largest fines – half
civil, half criminal – for illegal promotion of its drugs for
unapproved uses. The fine -- $2.4 billion – avoided criminal charges
and prosecution, either of the company or officials, and became just
another cost of doing business.

Just last week, soon after buying Wyeth Labs for $68 billion, Pfizer’s
CEO, Jeffrey B. Kindler, told a reporter for The New York Times that
his company has “invented too few drugs and left its reputation in
disrepair after two criminal cases.”

That record does not diminish Pfizer’s advantage over its imperiled
lab workers, which is built on the absence of any available risk
assessments, the very nature of possible latent, silent violence, and
the cruel refusal to give afflicted employees their own exposure
records on the grounds that they are company trade secrets.

Pfizer offered Ms. McClain a paltry sum with a gag order, which she
promptly refused. She wanted her freedom of speech and her whistle-
blowing rights under federal law. Her lawsuit was filed in 2006 in
Hartford.

By dismissing the third count, which might be appealed, in her
complaint alleging Pfizer’s wanton misconduct, U.S. District Judge
Vanessa L. Bryant ruled that the plaintiff did not have available the
evidence of causality and it was a worker’s compensation matter
anyway. Herein started the chicken-egg problem. How could Ms. McClain
obtain the evidence in order to prove her case when Pfizer said it was
proprietary and secret?

The Council for Responsible Genetics (CRG), started by Harvard and MIT
scientists, does not believe laboratory exposure records of workers
should be trade secrets. Life, health and remedial rights should trump
any such alleged, bizarre property right.

Becky McClain has already exhausted any remedies or assistance from
the woeful Occupational Safety and Health Administration (OSHA). This
agency has been without any regulations or disclosure requirements
about biohazards in laboratories. This inertness might change with the
appointment of David Michaels to head OSHA, which should bring the
agency closer to its mission of preventing or diminishing tens of
thousands of fatalities and injuries each year.

Mr. Michaels told the Times that “new biological materials,
nanomaterials, there are many things where we don’t have adequate
information, and we think workers need to have protection.” He
indicated that OSHA will take another look at the McClain case.

Both Jeremy Gruber, president of CRG, and Steve Zeltzer, chair of the
California Coalition for Workers Memorial Day, believe the McClain
case will lead to broader scrutiny of biologic laboratories, where
research is expanding rapidly with heavy federal funding.

It is well known that workers in these labs are inhibited from
speaking out, either inside or outside their workplace, for fear of
losing their jobs. OSHA has long known that companies in old and new
industries often do not come close to fully reporting cases of their
injuries and sickness either to their insurers or to state or federal
job safety agencies. Some have been found to keep two sets of books.

The Bureau of Labor Statistics data are not at all comprehensive.
Under-reporting can hide half or three-fourths of the actual traumatic
injuries.

Mr. Zeltzer has denounced what he calls “the failure of top company
officials to even report to OSHA and other government agencies that
many workers were getting sick numerous times in their laboratories
although this is required by the law.” He called on the US Attorney in
Hartford to begin a criminal investigation. (see
workersmemorialday.org)

As for Becky McClain, this is just the end of the beginning. She says
she has lost her career, her health and her health insurance. But she
recognizes her case is in the vanguard of many other cases and worker
protests to come before enforceable and openly accessible standards
and practices become the way of doing business for these labs.

For when it comes to developing materials that are inherently latent,
subvisible forms of silent violence, business as usual can become
cruel and unusual punishment for innocent, defenseless scientists, lab
technicians and other workers.

Such is the weighty responsibility of David Michaels and the new
managers of the long moribund, underfunded OSHA in the coming months.


"[Real] scientists are *fiercely* independent. That's the good
news."-- NIH's Top Fool, Anthony Fauci

0 new messages